CC312 Clinical Trials
4 recruitingBiologic
Phase 12Early Phase 12
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
A Study of CC312 for Relapsed/Refractory Autoimmune Diseases
SLE - Systemic Lupus ErythematosusSSc-Systemic SclerosisIIM- Idiopathic Inflammatory Myopathies
CytoCares Inc6 enrolled1 locationNCT07193810
Recruiting
Phase 1
Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies
CytoCares Inc44 enrolled1 locationNCT06037018
Recruiting
Early Phase 1
Safety Study of CC312 in Autoimmune Disease Patients
Rheumatoid Arthritis (RA)Autoimmune Hemolytic AnemiaSystemic Lupus Erythematosus (SLE)+3 more
CytoCares Inc18 enrolled1 locationNCT06888960
Recruiting
Phase 1
Safety and Efficacy Study of CC312 for Moderate to Severe SLE
SLE - Systemic Lupus Erythematosus
CytoCares Inc32 enrolled1 locationNCT07177911